Pharmaceuticals & Biotechnology (4570)

20,270.94
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

Ambrose exercises ValiRx oncology option worth up to £16m

By Josh White

Date: Friday 20 Jun 2025

(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth up to £16m plus royalties.

Pharmaceuticals & Biotechnology ShareCast News

GSK hoping to expand Arexvy usage in Japan 20-Jun-2025 ShareCast
SkinBioTherapeutics inks Superdrug deal, raises ... 16-Jun-2025 ShareCast
Eden Research enters strategic partnership with ... 16-Jun-2025 ShareCast
AstraZeneca launches strategic research collabor... 13-Jun-2025 ShareCast
GSK's RSV vaccine accepted for regulatory review... 13-Jun-2025 ShareCast

Pharmaceuticals & Biotechnology Regulatory News

Result of AGM 20-Jun-2025 07:00 RNS
Result of WRAP Retail Offer 20-Jun-2025 07:00 RNS
Arexvy filed in Japan for 18-49 at increased risk 20-Jun-2025 07:00 RNS
Transaction in Own Shares 20-Jun-2025 07:00 RNS
Transaction in Own Shares 20-Jun-2025 07:00 RNS

Pharmaceuticals & Biotechnology Newspaper Links

Small companies roundup: Sinclair IS Pharma cons... 27-Nov-2014 Express & Star
MARKET REPORT: Buyers lining up for Sinclair sal... 26-Nov-2014 Daily Mail
Reneuron tests stem cell stroke treatment 03-Sep-2014 The Herald
AstraZeneca buys the rights to an asthma treatme... 13-Jun-2014 Daily Mail
AstraZeneca in new £138million asthma drug deal 13-Jun-2014 Express & Star

Pharmaceuticals & Biotechnology Tips & Analysis

Questor :GW Pharmaceuticals 04-Dec-2014 Telegraph
Questor : Hikma Pharmaceuticals 13-Mar-2014 Telegraph
Investment Column:BTG 06-Oct-2011 The Independent
Investment Column:Genus 09-Sep-2011 The Independent
Questor :Dechra Pharmaceuticals 08-Sep-2011 Telegraph

Pharmaceuticals & Biotechnology News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 20,270.94
Closing Price Change -280.25
% Change -1.36 %
20-Jun-25 Close 20,270.94

Top Risers

Price Change
VAL 0.68p +22.7%
AVCT 32.50p +6.6%
OBI 14.40p +5.9%
IMM 2.40p +5.0%
HELD 0.99p +4.2%
EDEN 3.75p +4.2%
ANP 407.50p +3.2%
OXB 321.00p +2.4%
INDV 1,047.00p +1.9%
PRM 3.04p +1.7%

Top Fallers

Price Change
SCLP 9.40p -3.8%
APTA 0.32p -3.1%
GSK 1,402.50p -2.3%
BMK 24.00p -1.6%
HEMO 172.25p -1.6%
AZN 10,392.00p -1.5%
SVNS 0.17p -0.9%
ANIC 7.00p -0.7%
HCM 219.00p -0.5%
SBTX 16.63p -0.0%

Top of Page